NM_024301.5:c.427C>A

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2

The NM_024301.5(FKRP):​c.427C>A​(p.Arg143Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00524 in 1,493,634 control chromosomes in the GnomAD database, including 31 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R143L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0036 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0054 ( 30 hom. )

Consequence

FKRP
NM_024301.5 missense

Scores

4
13

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:17

Conservation

PhyloP100: 1.56

Publications

12 publications found
Variant links:
Genes affected
FKRP (HGNC:17997): (fukutin related protein) This gene encodes a protein which is targeted to the medial Golgi apparatus and is necessary for posttranslational modification of dystroglycan. Mutations in this gene have been associated with congenital muscular dystrophy, cognitive disability, and cerebellar cysts. Several alternatively spliced transcript variants of this gene have been described, but the full-length nature of some of these variants has not been determined. [provided by RefSeq, Oct 2008]
FKRP Gene-Disease associations (from GenCC):
  • autosomal recessive limb-girdle muscular dystrophy type 2I
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, Ambry Genetics
  • muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: G2P, Genomics England PanelApp, Ambry Genetics
  • muscular dystrophy-dystroglycanopathy type B5
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health
  • myopathy caused by variation in FKRP
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • congenital muscular dystrophy with cerebellar involvement
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy with intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • congenital muscular dystrophy without intellectual disability
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscle-eye-brain disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • muscular dystrophy-dystroglycanopathy, type A
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 46 curated pathogenic missense variants (we use a threshold of 10). The gene has 2 curated benign missense variants. Gene score misZ: 1.8498 (below the threshold of 3.09). Trascript score misZ: -2.4986 (below the threshold of 3.09). GenCC associations: The gene is linked to muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5, muscle-eye-brain disease, congenital muscular dystrophy with cerebellar involvement, muscular dystrophy-dystroglycanopathy, type A, autosomal recessive limb-girdle muscular dystrophy type 2I, muscular dystrophy-dystroglycanopathy type B5, congenital muscular dystrophy without intellectual disability, myopathy caused by variation in FKRP, congenital muscular dystrophy with intellectual disability.
BP4
Computational evidence support a benign effect (MetaRNN=0.009333223).
BP6
Variant 19-46755877-C-A is Benign according to our data. Variant chr19-46755877-C-A is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 129057.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00362 (551/152318) while in subpopulation NFE AF = 0.00609 (414/68012). AF 95% confidence interval is 0.0056. There are 1 homozygotes in GnomAd4. There are 250 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 30 AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024301.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FKRP
NM_024301.5
MANE Select
c.427C>Ap.Arg143Ser
missense
Exon 4 of 4NP_077277.1Q9H9S5
FKRP
NM_001039885.3
c.427C>Ap.Arg143Ser
missense
Exon 4 of 4NP_001034974.1Q9H9S5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
FKRP
ENST00000318584.10
TSL:1 MANE Select
c.427C>Ap.Arg143Ser
missense
Exon 4 of 4ENSP00000326570.4Q9H9S5
FKRP
ENST00000391909.7
TSL:2
c.427C>Ap.Arg143Ser
missense
Exon 4 of 4ENSP00000375776.2Q9H9S5
FKRP
ENST00000908841.1
c.427C>Ap.Arg143Ser
missense
Exon 3 of 3ENSP00000578900.1

Frequencies

GnomAD3 genomes
AF:
0.00363
AC:
552
AN:
152204
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00101
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00353
Gnomad ASJ
AF:
0.00317
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00434
Gnomad FIN
AF:
0.000188
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00610
Gnomad OTH
AF:
0.00335
GnomAD2 exomes
AF:
0.00448
AC:
445
AN:
99432
AF XY:
0.00418
show subpopulations
Gnomad AFR exome
AF:
0.000893
Gnomad AMR exome
AF:
0.00501
Gnomad ASJ exome
AF:
0.00342
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00661
Gnomad OTH exome
AF:
0.00730
GnomAD4 exome
AF:
0.00542
AC:
7272
AN:
1341316
Hom.:
30
Cov.:
32
AF XY:
0.00540
AC XY:
3552
AN XY:
657222
show subpopulations
African (AFR)
AF:
0.000995
AC:
30
AN:
30144
American (AMR)
AF:
0.00535
AC:
160
AN:
29892
Ashkenazi Jewish (ASJ)
AF:
0.00278
AC:
62
AN:
22330
East Asian (EAS)
AF:
0.0000286
AC:
1
AN:
35016
South Asian (SAS)
AF:
0.00478
AC:
350
AN:
73148
European-Finnish (FIN)
AF:
0.000336
AC:
11
AN:
32716
Middle Eastern (MID)
AF:
0.00736
AC:
39
AN:
5300
European-Non Finnish (NFE)
AF:
0.00597
AC:
6311
AN:
1056860
Other (OTH)
AF:
0.00551
AC:
308
AN:
55910
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
441
882
1324
1765
2206
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
252
504
756
1008
1260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00362
AC:
551
AN:
152318
Hom.:
1
Cov.:
33
AF XY:
0.00336
AC XY:
250
AN XY:
74486
show subpopulations
African (AFR)
AF:
0.00101
AC:
42
AN:
41572
American (AMR)
AF:
0.00353
AC:
54
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00317
AC:
11
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5176
South Asian (SAS)
AF:
0.00434
AC:
21
AN:
4834
European-Finnish (FIN)
AF:
0.000188
AC:
2
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00609
AC:
414
AN:
68012
Other (OTH)
AF:
0.00331
AC:
7
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
31
61
92
122
153
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00467
Hom.:
0
Bravo
AF:
0.00405
TwinsUK
AF:
0.00431
AC:
16
ALSPAC
AF:
0.00208
AC:
8
ESP6500AA
AF:
0.00106
AC:
4
ESP6500EA
AF:
0.00491
AC:
37
ExAC
AF:
0.00190
AC:
177
Asia WGS
AF:
0.000868
AC:
3
AN:
3470

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
6
not specified (6)
-
-
4
not provided (4)
-
-
3
Autosomal recessive limb-girdle muscular dystrophy type 2I (3)
-
-
1
Autosomal recessive limb-girdle muscular dystrophy type 2I;C1847759:Muscular dystrophy-dystroglycanopathy type B5;C3150413:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A5;C4284790:Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 (1)
-
-
1
Cardiovascular phenotype (1)
-
-
1
Primary dilated cardiomyopathy;C0007194:Hypertrophic cardiomyopathy;C0878544:Cardiomyopathy (1)
-
-
1
Walker-Warburg congenital muscular dystrophy (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.22
BayesDel_addAF
Benign
-0.043
T
BayesDel_noAF
Pathogenic
0.17
CADD
Benign
21
DANN
Benign
0.97
DEOGEN2
Benign
0.40
T
Eigen
Benign
-0.32
Eigen_PC
Benign
-0.27
FATHMM_MKL
Benign
0.67
D
LIST_S2
Benign
0.66
T
MetaRNN
Benign
0.0093
T
MetaSVM
Pathogenic
0.87
D
MutationAssessor
Benign
1.4
L
PhyloP100
1.6
PrimateAI
Pathogenic
0.80
T
PROVEAN
Benign
-1.8
N
REVEL
Pathogenic
0.69
Sift
Benign
0.58
T
Sift4G
Benign
0.085
T
Polyphen
0.18
B
Vest4
0.58
MVP
0.98
MPC
0.83
ClinPred
0.0045
T
GERP RS
3.6
Varity_R
0.59
gMVP
0.79
Mutation Taster
=55/45
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148206382; hg19: chr19-47259134; COSMIC: COSV105190863; COSMIC: COSV105190863; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.